Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review

Review of 26 studies concludes based on low- to moderate-strength evidence, buspirone, cannabinoids, and SSRIs are ineffective for decreasing cannabis use or improving abstinence. Evidence is limited because of small sample sizes and other methodological flaws.

Source:

Annals of Internal Medicine